Why the study?
Does indapamide reduce blood pressure in hypertensive patients?
Does indapamide reduce blood pressure in hypertensive patients?
Indapamide 2.5 to 5 mg per day effectively reduces blood pressure in hypertensive patients with a favorable safety profile.
Answers are grounded in this paper and cite their sources.
Supports indapamide for BP reduction in hypertension; leaves open durability, safety in broader populations, and comparisons to current first-line agents.
SummaryA placebo-controlled trial was carried out in 20 hypertensive patients to evaluate the therapeutic efficacy of 2.5 mg indapamide per day. Hypertension had been present for at least 2 years in all patients and they had previously been treated with a variety of other antihypertensive drugs. These were withdrawn on entry to the trial and patients received 1 tablet of placebo per day for 15 days before being treated with 1 tablet (2.5 mg) indapamide per day for 1 month. The results showed a statistically significant decrease in systolic, diastolic, and mean arterial blood pressures compared with after placebo, with a level of antihypertensive effect similar to that of the previous treatment. In 8 patients who did not show a satisfactory response, treatment was continued for a further month on 5 mg indapamide per day. A reduction in blood pressure levels occurred and was associated at this higher dosage with a significantly increased urine output. Subjective symptoms such as headache, dizziness and tinnitus responded satisfactorily to treatment, and side-effects were absent, apart from transient weakness reported by 1 patient on the 5 mg regimen. Blood sugar levels remained unchanged in all patients, including the 4 diabetics who were treated, and no significant changes were noted in any of the other clinical or biochemical parameters investigated.
No takes yet. Share an insight, caveat, or question.
Schlesinger et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: